Compare Cadila Healthcare with Cipla - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE CIPLA CADILA HEALTHCARE/
CIPLA
 
P/E (TTM) x 17.2 28.1 61.0% View Chart
P/BV x 3.1 4.0 78.2% View Chart
Dividend Yield % 0.9 0.6 159.9%  

Financials

 CADILA HEALTHCARE   CIPLA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-21
CIPLA
Mar-21
CADILA HEALTHCARE/
CIPLA
5-Yr Chart
Click to enlarge
High Rs509879 58.0%   
Low Rs259411 63.0%   
Sales per share (Unadj.) Rs147.5237.6 62.1%  
Earnings per share (Unadj.) Rs20.929.8 70.1%  
Cash flow per share (Unadj.) Rs28.043.0 65.0%  
Dividends per share (Unadj.) Rs3.505.00 70.0%  
Avg Dividend yield %0.90.8 117.5%  
Book value per share (Unadj.) Rs126.9226.7 56.0%  
Shares outstanding (eoy) m1,023.74806.46 126.9%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x2.62.7 95.9%   
Avg P/E ratio x18.421.6 84.9%  
P/CF ratio (eoy) x13.715.0 91.6%  
Price / Book Value ratio x3.02.8 106.4%  
Dividend payout %16.816.8 99.8%   
Avg Mkt Cap Rs m393,092519,826 75.6%   
No. of employees `000NANA-   
Total wages/salary Rs m22,54832,518 69.3%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m151,022191,596 78.8%  
Other income Rs m4492,698 16.6%   
Total revenues Rs m151,471194,294 78.0%   
Gross profit Rs m31,33542,487 73.8%  
Depreciation Rs m7,24810,677 67.9%   
Interest Rs m1,6881,607 105.0%   
Profit before tax Rs m22,84832,901 69.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4728,888 16.6%   
Profit after tax Rs m21,37624,013 89.0%  
Gross profit margin %20.722.2 93.6%  
Effective tax rate %6.427.0 23.8%   
Net profit margin %14.212.5 112.9%  
BALANCE SHEET DATA
Current assets Rs m87,160132,095 66.0%   
Current liabilities Rs m78,61345,916 171.2%   
Net working cap to sales %5.745.0 12.6%  
Current ratio x1.12.9 38.5%  
Inventory Days Days3368 49.2%  
Debtors Days Days767 1,151.4%  
Net fixed assets Rs m140,943116,277 121.2%   
Share capital Rs m1,0241,613 63.5%   
"Free" reserves Rs m128,899181,232 71.1%   
Net worth Rs m129,923182,844 71.1%   
Long term debt Rs m6,09512,028 50.7%   
Total assets Rs m228,103248,372 91.8%  
Interest coverage x14.521.5 67.7%   
Debt to equity ratio x00.1 71.3%  
Sales to assets ratio x0.70.8 85.8%   
Return on assets %10.110.3 98.0%  
Return on equity %16.513.1 125.3%  
Return on capital %18.017.7 101.9%  
Exports to sales %031.3 0.0%   
Imports to sales %10.510.9 96.5%   
Exports (fob) Rs mNA59,951 0.0%   
Imports (cif) Rs m15,91120,911 76.1%   
Fx inflow Rs m63,53568,051 93.4%   
Fx outflow Rs m15,91120,911 76.1%   
Net fx Rs m47,62447,140 101.0%   
CASH FLOW
From Operations Rs m32,93037,552 87.7%  
From Investments Rs m-7,225-23,872 30.3%  
From Financial Activity Rs m-25,489-13,299 191.7%  
Net Cashflow Rs m-905509 -177.8%  

Share Holding

Indian Promoters % 74.9 14.3 522.9%  
Foreign collaborators % 0.0 21.8 -  
Indian inst/Mut Fund % 15.7 45.9 34.1%  
FIIs % 3.8 24.4 15.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 63.9 39.3%  
Shareholders   370,931 451,365 82.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   SUN PHARMA    LUPIN    AUROBINDO PHARMA    DR. REDDYS LAB    PIRAMAL ENTERPRISES    



Today's Market

Maruti Suzuki Quarterly Results, Oyo's Rs 84 bn IPO, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a positive note on Tuesday. Benchmark indices snapped their five-day losing run and ended on a positive note in a highly volatile session.

Related Views on News

CIPLA 2020-21 Annual Report Analysis (Annual Result Update)

Oct 20, 2021 | Updated on Oct 20, 2021

Here's an analysis of the annual report of CIPLA for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of CIPLA. Also includes updates on the valuation of CIPLA.

CADILA HEALTHCARE Announces Quarterly Results (1QFY22); Net Profit Up 35.0% (Quarterly Result Update)

Aug 16, 2021 | Updated on Aug 16, 2021

For the quarter ended June 2021, CADILA HEALTHCARE has posted a net profit of Rs 6 bn (up 35.0% YoY). Sales on the other hand came in at Rs 40 bn (up 14.5% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

5 Indian Pharma Companies Riding the Vaccination Wave (Views On News)

Sep 3, 2021

These companies are likely to benefit the most from Covid-19 vaccines.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 25, 2022 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS